All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1122-YF521 | Anti-IL13RA2 KIR CAR (scFv-KIR2DS2-DAP12, XW-521), pCDCAR1 | Human | XW-521 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF522 | Anti-IL13RA2 KIR CAR (scFv-KIR2DS2-DAP12, XW-522), pCDCAR1 | Human | XW-522 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF523 | Anti-IL13RA2 KIR CAR (scFv-KIR2DS2-DAP12, XW-523), pCDCAR1 | Human | XW-523 | Human | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF524 | Anti-IL13RA2 KIR CAR (scFv-KIR2DS2-DAP12, XW-524), pCDCAR1 | Human | XW-524 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF525 | Anti-IL13RA2 KIR CAR (scFv-KIR2DS2-DAP12, XW-525), pCDCAR1 | Mouse | XW-525 | Rabbit | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF1441 | Anti-IL13RA2 TCR-ABR (scFv-TCRα, XW-521) CAR Plasmid, pCDCAR1 | Human | XW-521 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1442 | Anti-IL13RA2 TCR-ABR (scFv-TCRα, XW-522) CAR Plasmid, pCDCAR1 | Human | XW-522 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1443 | Anti-IL13RA2 TCR-ABR (scFv-TCRα, XW-523) CAR Plasmid, pCDCAR1 | Human | XW-523 | Human | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1444 | Anti-IL13RA2 TCR-ABR (scFv-TCRα, XW-524) CAR Plasmid, pCDCAR1 | Human | XW-524 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1445 | Anti-IL13RA2 TCR-ABR (scFv-TCRα, XW-525) CAR Plasmid, pCDCAR1 | Mouse | XW-525 | Rabbit | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF2361 | Anti-IL13RA2 TCR-ABR (scFv-TCRβ, XW-521) CAR Plasmid, pCDCAR1 | Human | XW-521 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2362 | Anti-IL13RA2 TCR-ABR (scFv-TCRβ, XW-522) CAR Plasmid, pCDCAR1 | Human | XW-522 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2363 | Anti-IL13RA2 TCR-ABR (scFv-TCRβ, XW-523) CAR Plasmid, pCDCAR1 | Human | XW-523 | Human | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2364 | Anti-IL13RA2 TCR-ABR (scFv-TCRβ, XW-524) CAR Plasmid, pCDCAR1 | Human | XW-524 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2365 | Anti-IL13RA2 TCR-ABR (scFv-TCRβ, XW-525) CAR Plasmid, pCDCAR1 | Mouse | XW-525 | Rabbit | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3281 | Anti-IL13RA2 TCR-ABR (scFv-CD3γ, XW-521) CAR Plasmid, pCDCAR1 | Human | XW-521 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3282 | Anti-IL13RA2 TCR-ABR (scFv-CD3γ, XW-522) CAR Plasmid, pCDCAR1 | Human | XW-522 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3283 | Anti-IL13RA2 TCR-ABR (scFv-CD3γ, XW-523) CAR Plasmid, pCDCAR1 | Human | XW-523 | Human | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3284 | Anti-IL13RA2 TCR-ABR (scFv-CD3γ, XW-524) CAR Plasmid, pCDCAR1 | Human | XW-524 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3285 | Anti-IL13RA2 TCR-ABR (scFv-CD3γ, XW-525) CAR Plasmid, pCDCAR1 | Mouse | XW-525 | Rabbit | scFv-CD3γ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION